Vismodegib and risk of cholestatic injury: should we screen candidate patients?

Clin Exp Med. 2017 Aug;17(3):415-416. doi: 10.1007/s10238-016-0433-2. Epub 2016 Aug 2.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anilides*
  • Antineoplastic Agents
  • Humans
  • Pyridines*
  • Skin Neoplasms

Substances

  • Anilides
  • Antineoplastic Agents
  • HhAntag691
  • Pyridines